---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-018318"
form_type: "8-K"
ticker: "STEX"
cik: "0001530766"
company_name: "Streamex Corp."
filed_at: "2025-07-09T23:59:59+00:00"
generated_at: "2026-05-18T08:53:10.468420+00:00"
event_type: "debt"
sentiment: "positive"
materiality_score: 0.95
calibrated_materiality_score: 0.95
confidence: "high"
source: SEC EDGAR
---

# BioSig announces up to $1.1B financing: $100M convertible debentures + $1B equity line for gold tokenization

## Summary
- Issues $75M first tranche convertible debenture at 96% of par, 4% interest, 24-month maturity; conversion price tied to VWAP with 20% floor and 19.99% exchange cap.
- Second $25M tranche requires SEC registration effectiveness; proceeds to acquire gold bullion and develop Solana-based RWA tokenization platform.
- SEPA allows sale of up to $1B common stock over 36 months at 97% of 3-day VWAP; subject to exchange cap unless shareholder approval or price >= $9.414.
- Insiders sign 180-day lock-up; Cantor, Clear Street, Needham lead placement; CIBC advising; closing expected by Oct 7, 2025 subject to shareholder approval.

## SEC filing metadata
- accession: 0001641172-25-018318
- form_type: 8-K
- ticker: STEX
- cik: 0001530766
- company_name: Streamex Corp.
- filed_at: 2025-07-09T23:59:59+00:00
- event_type: debt
- sentiment: positive
- materiality_score: 0.95
- calibrated_materiality_score: 0.95
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1530766/000164117225018318/0001641172-25-018318-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1530766/000164117225018318/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-018318
- JSON: https://secwatch.observer/filing/0001641172-25-018318.json
- Plain text: https://secwatch.observer/filing/0001641172-25-018318.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.